BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26523627)

  • 1. AMH MEASUREMENT VERSUS OVARIAN ULTRASOUND IN THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME IN DIFFERENT PHENOTYPES.
    Carmina E; Campagna AM; Fruzzetti F; Lobo RA
    Endocr Pract; 2016 Mar; 22(3):287-93. PubMed ID: 26523627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T; Panichyawat N; Indhavivadhana S; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Pratumvinit B; Sa-Nga-Areekul N
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
    Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR
    Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.
    Dewailly D; Lujan ME; Carmina E; Cedars MI; Laven J; Norman RJ; Escobar-Morreale HF
    Hum Reprod Update; 2014; 20(3):334-52. PubMed ID: 24345633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between serum anti-Mullerian hormone and clinical parameters in polycystic ovary syndrome.
    Matsuzaki T; Munkhzaya M; Iwasa T; Tungalagsuvd A; Yano K; Mayila Y; Yanagihara R; Tokui T; Kato T; Kuwahara A; Matsui S; Irahara M
    Endocr J; 2017 May; 64(5):531-541. PubMed ID: 28381699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria].
    Yang S; Ruan J; Huang W; Tan J; Zhang X; Feng X; Liu D; Fu J; Zhou L; Zhou M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):819-24. PubMed ID: 26887768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasonographic criteria in the diagnosis of polycystic ovary syndrome: a systematic review and diagnostic meta-analysis.
    Pea J; Bryan J; Wan C; Oldfield AL; Ganga K; Carter FE; Johnson LM; Lujan ME
    Hum Reprod Update; 2024 Jan; 30(1):109-130. PubMed ID: 37804097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes.
    Romualdi D; Di Florio C; Tagliaferri V; De Cicco S; Gagliano D; Immediata V; Lanzone A; Guido M
    Reprod Sci; 2016 May; 23(5):655-61. PubMed ID: 26718304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
    Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women.
    Yue CY; Lu LK; Li M; Zhang QL; Ying CM
    PLoS One; 2018; 13(8):e0203129. PubMed ID: 30153296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features.
    Pawelczak M; Kenigsberg L; Milla S; Liu YH; Shah B
    J Pediatr Endocrinol Metab; 2012; 25(9-10):983-9. PubMed ID: 23426830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicle number, not assessments of the ovarian stroma, represents the best ultrasonographic marker of polycystic ovary syndrome.
    Christ JP; Willis AD; Brooks ED; Vanden Brink H; Jarrett BY; Pierson RA; Chizen DR; Lujan ME
    Fertil Steril; 2014 Jan; 101(1):280-287.e1. PubMed ID: 24188871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.
    Łebkowska A; Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Milewski R; Górska M; Wołczyński S; Kowalska I
    Metabolism; 2016 May; 65(5):804-811. PubMed ID: 26961579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimüllerian hormone to determine polycystic ovarian morphology.
    Dietz de Loos A; Hund M; Buck K; Meun C; Sillman J; Laven JSE
    Fertil Steril; 2021 Oct; 116(4):1149-1157. PubMed ID: 34579824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Piouka A; Livadas S; Piperi C; Katsikis I; Papavassiliou AG; Panidis D
    Eur J Endocrinol; 2009 May; 160(5):847-53. PubMed ID: 19208775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved diagnostic performance for the diagnosis of polycystic ovary syndrome using age-stratified criteria.
    Ahmad AK; Quinn M; Kao CN; Greenwood E; Cedars MI; Huddleston HG
    Fertil Steril; 2019 Apr; 111(4):787-793.e2. PubMed ID: 30871762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.